E10
Conditions
Interventions
Group 1: At several children's hospitals in Germany, 210 children with type 1 diabetes mellitus take part in a one-time questionnaire before the upcoming diabetes training: the Paediatric Self-Efficac
Sponsors
University Witten/HerdeckeHealth Department
Eligibility
Sex/Gender
All
Age
12 Years to 17 Years
Inclusion criteria
Inclusion criteria: Inclusion criterion for the first substudy - Adult members of the diabetes team (= 18 years of age) who are involved in the development and/or delivery of diabetes training for type 1 diabetes at Herdecke Community Hospital. - A prerequisite for participation in the study is a written declaration of consent. Inclusion criteria for the second sub-study - Children/adolescents with diabetes mellitus type 1 ( = 12 years of age and = 17 years of age) - A prerequisite for participation in the study is a written declaration of consent from the study participants as well as a written declaration of consent from the guardians.
Exclusion criteria
Exclusion criteria: Exclusion criterion for the first substudy - Insufficient physical, cognitive and emotional skills to handle the tests. Exclusion criteria for the second substudy - Insufficient German language skills to understand the test/the declaration of consent. - Insufficient physical, cognitive and emotional abilities of the children to handle the tests. - Particularly onerous extraordinary events that are contradictory to participation in the study. - The following, in particular, are considered exclusion criteria for the children: a known, abnormal haemoglobin level, an abnormal creatinine level, alcoholism or long-term aspirin therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. First cross-sectional study. What: Primary endpoint is the diabetes-related self-efficacy that was measured by the PSEDT-1 questionnaire. When: The first sample consists of 210 children treated in the children's hospitals between 2012 and 2014. How: The sample was recruited at eleven children's hospitals in Germany. In this phase of the study, the opening questionnaire and the PSEDT-1 were completed after education had been given and the written consent of the parents and children had been obtained. 2. Longitudinal study. What: Diabetes-related self-efficacy that was measured using the PSEDT-1 questionnaire. When: The second sample to determine sensitivity to change consisted of 80 outpatient and inpatient children and adolescents who attended a diabetes training course at Herdecke Community Hospital between 2012 and 2014. How: In this sample, the opening questionnaire and the questionnaire to determine self-efficacy were completed three times. The dates for the surveys were 1–16 weeks before the diabetes training, at the beginning of the diabetes training, and six months after completion of the diabetes training. 3. Second cross-sectional study. What: Diabetes-related self-efficacy is measured using the PSEDT-1 questionnaire. When: The study will run between 2017 and 2020. How: In a second phase of the study, the confirmatory reliability of the PSEDT-1 questionnaire will be tested in cooperation with the University Hospital Schleswig Holstein as part of the project "Virtual Diabetes Outpatient Clinic". Included in this study are 240 children receiving care from a diabetologist in Schleswig-Holstein (clinic or practice, diabetologist/paediatrician or diabetologist/internist). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. First cross-sectional study. What: Secondary endpoints are locus control and self-esteem. How: Supplementary questionnaires are also completed: the "KKG" questionnaire to survey loci of control on disease and health, and the multidimensional self-esteem scale, "MSWS", for recording facets of self-esteem assessment. When: The sample consisted of a cross-section of 210 adolescents altogether, who were treated in the children's hospitals between 2012 and 2014. Where: Sample was recruited at eleven children's hospitals in Germany. In this sample, the KKG and MSWS surveys were completed after education had been carried out and written declaration of consent from the parents and children had been obtained. | — |
Countries
Germany
Contacts
Public ContactDörte Hilgard
Dr. med. Dörte HilgardÄrztin, KinderärztinWeiterbildungen: Kinder- Endokrinol. & - Diabetologie
Outcome results
None listed